PubMed:18285341 / 1008-1211
Annnotations
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T15 | 139-146 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
T17 | 187-202 | Glycan_Motif | denotes | keratan sulfate | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G82109MW |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T5 | 148-163 | GlycoEpitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T6 | 187-202 | GlycoEpitope | denotes | keratan sulfate | http://www.glycoepitope.jp/epitopes/EP0085 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 0-203 | Sentence | denotes | Measurements following chondroitinase ABC treatment of the cell lysates demonstrated no change in the content of the other sGAG, including heparin, heparan sulfate, dermatan sulfate, and keratan sulfate. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 139-146 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T12 | 139-146 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T13 | 187-202 | https://glytoucan.org/Structures/Glycans/G82109MW | denotes | keratan sulfate |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T8 | 187-202 | Glycan | denotes | keratan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G82109MW |
T18 | 148-163 | Glycan | denotes | heparan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T8 | 148-163 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T9 | 187-202 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | keratan sulfate | http://www.glycoepitope.jp/epitopes/EP0085 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 0-203 | Sentence | denotes | Measurements following chondroitinase ABC treatment of the cell lysates demonstrated no change in the content of the other sGAG, including heparin, heparan sulfate, dermatan sulfate, and keratan sulfate. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 0-203 | Sentence | denotes | Measurements following chondroitinase ABC treatment of the cell lysates demonstrated no change in the content of the other sGAG, including heparin, heparan sulfate, dermatan sulfate, and keratan sulfate. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T8 | 187-202 | Glycan | denotes | keratan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G82109MW |
T18 | 148-163 | Glycan | denotes | heparan sulfate | https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T8 | 148-163 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T9 | 187-202 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | keratan sulfate | http://www.glycoepitope.jp/epitopes/EP0085 |